Use of a Web-based clinical decision support system to improve abdominal aortic aneurysm screening in a primary care practice

Division of Primary Care Internal Medicine, Center for Innovation, Department of Family Medicine and Information Technology, Mayo Clinic, Rochester, MN 55905, USA.
Journal of Evaluation in Clinical Practice (Impact Factor: 1.58). 03/2011; 18(3):666-70. DOI: 10.1111/j.1365-2753.2011.01661.x
Source: PubMed

ABSTRACT The United States Preventive Services Task Force recommends a one-time screening for abdominal aortic aneurysm (AAA) with ultrasonography for men aged 65 to 75 years who have ever smoked. However, despite a mortality rate of up to 80% for ruptured AAAs, providers order the screening for a minority of patients. We sought to determine the effect of a Web-based point-of-care clinical decision support system on AAA screening rates in a primary care practice.
We conducted a retrospective review of medical records of male patients aged 65 to 75 years who were seen at any of our practice sites in 2007 and 2008, before and after implementation of the clinical decision support system.
Overall screening rates were 31.36% in 2007 and 44.09% in 2008 (P-value: <0.001). Of patients who had not had AAA screening prior to the visit, 3.22% completed the screening after the visit in 2007, compared with 18.24% in 2008 when the clinical support system was implemented, 5.36 times improvement (P-value: <0.001).
A Web-based clinical decision support for primary care physicians significantly improved delivery of AAA screening of eligible patients. Carefully developed clinical decision support systems can optimize care delivery, ensuring that important preventive services are delivered to eligible patients.


Available from: Kurt B Angstman, May 30, 2015
  • [Show abstract] [Hide abstract]
    ABSTRACT: The electronic medical record has evolved from a digital representation of individual patient results and documents to information of large scale and complexity. Big Data refers to new technologies providing management and processing capabilities, targeting massive and disparate data sets. For an individual patient, techniques such as Natural Language Processing allow the integration and analysis of textual reports with structured results. For groups of patients, Big Data offers the promise of large-scale analysis of outcomes, patterns, temporal trends, and correlations. The evolution of Big Data analytics moves us from description and reporting to forecasting, predictive modeling, and decision optimization.
    The Journal of ambulatory care management 07/2014; 37(3):206-210. DOI:10.1097/JAC.0000000000000037
  • [Show abstract] [Hide abstract]
    ABSTRACT: Colorectal cancer is the second leading cause of cancer-related deaths in the United States. However, 41% of patients do not receive adequate screening, since the surveillance guidelines for colonoscopy are complex and are not easily recalled by health care providers. As a potential solution, we developed a guideline based clinical decision support system (CDSS) that can interpret relevant freetext reports including indications, pathology and procedure notes. The CDSS was evaluated by comparing its recommendations with those of a gastroenterologist for a test set of 53 patients. The CDSS made the optimal recommendation in 48 cases, and helped the gastroenterologist revise the recommendation in 3 cases. We performed an error analysis for the 5 failure cases, and subsequently were able to modify the CDSS to output the correct recommendation for all the test cases. Results indicate that the system has a high potential for clinical deployment, but further evaluation and optimization is required. Limitations of our study are that the study was conducted at a single institution and with a single expert, and the evaluation did not include rare decision scenarios. Overall our work demonstrates the utility of natural language processing to enhance clinical decision support.
    Healthcare Informatics, Imaging and Systems Biology (HISB), 2012 IEEE Second International Conference on; 01/2012
  • [Show abstract] [Hide abstract]
    ABSTRACT: Abdominal aortic aneurysm (AAA) is a complex, multifactorial disease with a strong genetic component. About 20% of AAA patients have at least one relative with this condition. Since the first candidate gene studies were published 20 years ago, nearly 100 genetic association studies using single nucleotide polymorphisms (SNPs) in biologically relevant genes have been reported on AAA. The most significant results from candidate gene studies are for sortilin-1 (SORT1), interleukin 6 receptor (IL6R), and apolipoprotein(a) (LPA). Unbiased genome-wide approaches such as family-based DNA linkage studies and genome-wide association studies have been carried out by international consortia to identify susceptibility loci for AAA. The chromosomal regions in the human genome with the strongest supporting evidence of contribution to the genetic risk for AAA are: 1) CDKN2BAS gene (located on chromosome 9p21), also known as ANRIL, which encodes an antisense RNA that regulates expression of the cyclin-dependent kinase inhibitors CDKN2A and CDKN2B; 2) DAB2 interacting protein (DAB2IP; located on chromosome 9q33), which encodes an inhibitor of cell growth and survival; 3) low density lipoprotein receptor-related protein 1 (LRP1; located on chromosome 12q13.3), a plasma membrane receptor involved in vascular smooth muscle and macrophage endocytosis, 4) low density lipoprotein receptor (LDLR; located on chromosome 19p13.2), and 5) contactin-3 (CNTN3; located on chromosome 3p12.3), which demonstrated the strongest association in smokers and yet its function remains unclear. These five loci were identified in genome-wide association studies. Using a different approach, DNA linkage analysis with affected relative-pairs, two additional loci containing several plausible candidate genes, located on chromosomes 4q31 and 19q13, were discovered. On-going and future studies to find additional risk loci include large meta-analyses and whole genome sequencing. Furthermore, functional studies are needed to establish the mechanisms by which these genes contribute to AAA pathogenesis. In the long-term, these discoveries will result in important translational applications to the prevention, diagnosis and management of AAAs.
    Horizons in World Cardiovascular Research, vol. 7, Edited by EH Bennington, 01/2015: chapter 1; Nova Science Publishers, Inc., Hauppauge, NY., ISBN: 978-1-63463-861-6